Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection

A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants.

Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twice a…